|
Download data/downstream/final_data/drug_combination_synergy/data_summary/README.md from ctcatlas/BioMod: direct link, hf CLI and curl.
- Browser
- Download file 4.57 kB
-
https://huggingface.co/ctcatlas/BioMod/resolve/main/data/downstream/final_data/drug_combination_synergy/data_summary/README.md
- Command line
-
hf download hf://ctcatlas/BioMod/data/downstream/final_data/drug_combination_synergy/data_summary/README.md
-
curl -L -o README.md https://huggingface.co/ctcatlas/BioMod/resolve/main/data/downstream/final_data/drug_combination_synergy/data_summary/README.md
4.57 kB
DeepDDS core data files
The provenance and counts below are translated from the existing dataset notes. This path/comment audit did not recompute counts or validate the source studies.
Data sources
- Drug synergy: the O'Neil et al. (2016) high-throughput screen of pairwise combinations of 38 anticancer drugs across 39 human cancer cell lines.
- Synergy scores: Loewe Additivity Scores computed with Combenefit from 4 x 4 dose-response matrices. Replicate measurements for the same combination were averaged.
- Cell-line expression: CCLE RNA-seq TPM data released in 2018 (
CCLE_RNAseq_rsem_transcripts_tpm_20180929), describing baseline expression under standard culture conditions without drug treatment.
Binary labels
| Condition | Label | Meaning |
|---|---|---|
| Loewe score > 10 | 1 | Synergistic |
| Loewe score < 0 | 0 | Antagonistic |
| 0 <= score <= 10 | Excluded | Ambiguous range excluded from modeling |
The original notes describe the stricter positive threshold as intended to reduce near-zero noise and obtain roughly balanced classes.
Previously recorded dataset size
- 12,415 unique drug-pair/cell-line combinations.
- 36 anticancer drugs and 31 human cancer cell lines.
- 6,116 positive and 6,299 negative samples.
File descriptions
new_labels_0_10.csv: binary training labels
The recorded layout is 12,415 records plus one header row.
| Column | Type | Description |
|---|---|---|
| drug1 | string | SMILES representation of drug A |
| drug2 | string | SMILES representation of drug B |
| cell | string | Cell-line name, such as A375 or HCT116 |
| label | int | 0 = antagonistic (score < 0); 1 = synergistic (score > 10) |
score_0_10.csv: continuous synergy scores
The existing notes record 12,415 records plus a header, corresponding to new_labels_0_10.csv.
| Column | Type | Description |
|---|---|---|
| drug1 | string | Drug A name, such as 5-FU |
| drug2 | string | Drug B name, such as ABT-888 |
| cell | string | Cell-line name |
| score | float | Continuous Loewe Additivity Score |
| nor | float | Normalized score |
| index | int | Sample index |
| true_label | int | Binary ground-truth label |
| predict_label | int | Legacy predicted label |
| predict_score | float | Legacy prediction probability |
| smile1 | string | Drug A SMILES |
| smile2 | string | Drug B SMILES |
The stored prediction columns are historical reference results, not results from the current BioMod checkout.
new_cell_features_954.csv: cell-line expression
- Recorded dimensions: 31 cell lines x 954 genes.
- Source: CCLE baseline RNA-seq TPM, without drug treatment.
- Row 1: gene IDs (ENSG).
- Row 2: transcript IDs (ENST).
- Rows 3-33: expression values, with the cell-line name in the first column.
- Purpose: cell features encoded by fully connected layers and combined with drug graph features.
cell_gene954.csv: gene identifier table
- Recorded layout: 954 records plus a header.
- Columns:
gene_id(ENSG),transcript_id(ENST). - Purpose: identify the genes in
new_cell_features_954.csv.
smiles_0_10.csv: drug SMILES table
- The legacy notes record 36 headerless rows; counts may differ from the parser-based summary in the parent directory.
- Columns: drug name and SMILES representation.
- Purpose: map drug names to SMILES used for molecular-graph construction.
drugs_0_10.csv: drug table
- Recorded layout: 36 headerless rows.
- Columns: drug name, SMILES, numeric encoding.
- Purpose: enumerate drugs and their encoded indices.
cell_line_0_10.csv: cell-line table
- Recorded layout: 31 headerless rows.
- Columns: cell-line name and cancer type, such as melanoma, ovarian, or colon.
- Purpose: associate cell lines with cancer types.
DeepDDS inputs
Drug A SMILES -> Molecular graph -> GAT/GCN -> Drug A embedding --+
|
Drug B SMILES -> Molecular graph -> GAT/GCN -> Drug B embedding --+-> Concatenate -> FC layers -> Synergy prediction
|
Cell line (954 genes, TPM) -> FC layers -> Cell embedding -------+
References retained from the original notes
- Wang et al. "DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations." Briefings in Bioinformatics, 2022.
- O'Neil et al. "An unbiased oncology compound screen to identify novel combination strategies." Molecular Cancer Therapeutics, 2016.
- CCLE: Cancer Cell Line Encyclopedia, Broad Institute.